cisplatin,fluorouracil,sintilimab,paclitaxel
eli lilly,innovent biologics
['sintilimab', 'orient-15', 'esophageal', 'innovent']
innovent presents final analysis p-iii study (orient-15) results of sintilimab as 1l treatment of esophageal squamous cell carcinoma at aacr 2023 
Real-time summarized News in 3 shots from pharma, biotech, medtech, digital health and life sciences industry readable in 60 seconds